Review of: "Efficacy and Safety of External Extracorporeal Counterpulsation in Heart Failure with Preserved Ejection Fraction"

The article presents a thorough examination of Heart Failure with Preserved Ejection Fraction (HFpEF) and explores thepotential application of External Extracorporeal Counterpulsation (EECP) as a novel therapeutic intervention. HFpEF is achallenging cardiovascular disorder with significant healthcare implications, characterized by diastolic dysfunction leadingto symptoms such as shortness of breath and fatigue. Given the limited efficacy of traditional treatments for HFpEF, thearticle delves into the promise of EECP, a non-invasive therapy known to improve cardiovascular outcomes in othercontexts.